Thank you.
I guess we could think of it in two ways.
My colleague has already spoken very nicely about non-genetic technologies that can be used, so if these new technologies can be leveraged regardless of the genetic cause.... But if we're thinking about understanding why the gene goes wrong and causes a disease and how we can fix that, we have to recognize that sometimes genes work in pathways, so there may be a whole sequelae of genes. You can modulate one or the other, but they may eventually all converge on a pathway somewhere down lower. If you can modulate that target, you may have a successful treatment of 10 or 20 diseases along the pathway. I think we're going to have to think in that way. Researchers may not be able to work in their silo just studying their one disease. They may have to think about a category.